Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New protein vital for immune response is found in surprise location

26.08.2005


A newly discovered protein not only is vital to the immune system’s ability to fight off viral infections but also has been found in an unexpected location within the cell, causing researchers to rethink previous notions about the workings of the human immune system.



Researchers at UT Southwestern Medical Center said their findings may lead to new therapies aimed at preventing and treating viral diseases such as the flu, hepatitis, West Nile virus and SARS. The study is available online and will appear in the Sept. 9 issue of the journal Cell.

Working with cultured cells, researchers found that the protein, made by a gene they discovered and named MAVS, is located in an unexpected place within the cell - in the membrane of an organelle called the mitochondrion, which until now was best known for generating energy required for daily life.


"This is the first mitochondrial protein known to be involved in immune defense against any microbial infection," said Dr. Zhijian "James" Chen, associate professor of molecular biology at UT Southwestern and the study’s senior author. "This discovery puts mitochondria on the map in terms of immunity, and it opens up a new avenue of research in immunology."

The researchers modified normal cells so that the cells could not produce the MAVS protein, which is short for Mitochondrial Anti-Viral Signaling protein. Without MAVS, the cells were highly vulnerable to infection with two common viruses in a class called RNA viruses Other RNA viruses include hepatitis C, West Nile, SARS and the flu viruses.

Cells altered to produce an overabundance of MAVS were protected from dying from viral infection.

"These results raise the possibility that variations in the expression levels of MAVS may endow different individuals with varying ability to fight off viral diseases," said Dr. Chen, who also is an investigator with the Howard Hughes Medical Institute. "Viruses have evolved along with humans and have developed strategies to evade the host’s immunity. It’s quite possible that some viruses may target MAVS in order to achieve successful infection. In those cases, therapies that enhance MAVS expression or activity may be a viable option for boosting immune responses against viral diseases."

The fact that MAVS is located within the membrane of the mitochondrion makes sense for a couple of reasons, Dr. Chen said.

First, proteins housed within the mitochondria have been shown by researchers, such as UT Southwestern biochemist Dr. Xiaodong Wang and others, to play a role in apoptosis, or programmed cell death. The fact that MAVS is located in the membrane of mitochondria suggests it may play a role in coordinating cell death and immune response, Dr. Chen said.

Secondly, many scientists believe that mitochondria originally evolved from bacteria that lived within a host organism’s cells, eventually developing a symbiotic relationship with host cells. Now that mitochondria are an integral part of our cells, Dr. Chen speculated that mitochondria may have acquired new functions by serving as a sentinel to detect invading pathogens and other stressful signals, ensuring that the host cells survive and thrive even in adverse environments.

Dr. Chen and his research group are currently working to determine how the MAVS protein functions within the complex series of biochemical reactions that takes place when the body is infected with a virus.

Researchers at UT Southwestern, led by microbiologist Dr. Michael Gale, and elsewhere have previously found that when an RNA virus invades a cell, a protein called RIG-I first intercepts the virus and binds to viral genetic material. That interaction starts a cascade of biochemical reactions that eventually triggers the cell to make a protein called interferon, which in turn fights off the virus.

But the chain of events between RIG-I’s encounter with the virus and the interferon response is not known. Researchers have been trying to identify and characterize the proteins involved in an effort to better understand the nature of viral infection and how to combat it.

Dr. Chen said he and his group believe MAVS is among a group of molecules that play a role in activating other proteins - including IRF-3 and NF-kappaB - that prod the cell into making interferon. He also said there is evidence that MAVS binds with RIG-I, but more experiments are needed to determine just how MAVS functions within the cell.

Other UT Southwestern researchers involved in the studies were lead authors Rashu Seth, a graduate student research assistant, and Dr. Lijun Sun, a postdoctoral researcher in molecular biology, and Chee-Kwee Ea, a graduate student research assistant.

The research was supported by the National Institutes of Health, the Robert A. Welch Foundation, the Burroughs Wellcome Fund, the Leukemia and Lymphoma Society, the American Cancer Society, and the Howard Hughes Medical Institute.

Amanda Siegfried | EurekAlert!
Further information:
http://www.utsouthwestern.edu

More articles from Life Sciences:

nachricht Researchers uncover protein-based “cancer signature”
05.12.2016 | Universität Basel

nachricht The Nagoya Protocol Creates Disadvantages for Many Countries when Applied to Microorganisms
05.12.2016 | Leibniz-Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

IHP presents the fastest silicon-based transistor in the world

05.12.2016 | Power and Electrical Engineering

InLight study: insights into chemical processes using light

05.12.2016 | Materials Sciences

High-precision magnetic field sensing

05.12.2016 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>